BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28644180)

  • 41. Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease.
    Yasutomi E; Inokuchi T; Hiraoka S; Takei K; Igawa S; Yamamoto S; Ohmori M; Oka S; Yamasaki Y; Kinugasa H; Takahara M; Harada K; Furukawa M; Itoshima K; Okada K; Otsuka F; Tanaka T; Mitsuhashi T; Kato J; Okada H
    Sci Rep; 2021 May; 11(1):11086. PubMed ID: 34045529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies.
    Beigel F; Deml M; Schnitzler F; Breiteneicher S; Göke B; Ochsenkühn T; Brand S
    PLoS One; 2014; 9(6):e99293. PubMed ID: 24932476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease.
    Casellas F; Barreiro de Acosta M; Iglesias M; Robles V; Nos P; Aguas M; Riestra S; de Francisco R; Papo M; Borruel N
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):762-9. PubMed ID: 22517240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients.
    Choi SY; Choi YO; Choe YH; Kang B
    J Korean Med Sci; 2020 Apr; 35(16):e114. PubMed ID: 32329259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing.
    González-Partida I; Martínez-Lozano H; González-Lois C; Peligros I; Sánchez-Yuste R; Salas I; Matallana V; Bighelli F; Calvo M; Marín-Jiménez I; Salas C; Vera MI; Menchén L; González-Lama Y
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e796-e802. PubMed ID: 34334707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
    Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
    Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
    Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
    J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy.
    Hall B; Holleran G; Chin JL; Smith S; Ryan B; Mahmud N; McNamara D
    J Crohns Colitis; 2014 Dec; 8(12):1601-9. PubMed ID: 25257546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocytoscopy for assessing histologic inflammation in ulcerative colitis: development and prospective validation of the ELECT (ErLangen Endocytoscopy in ColiTis) score (with videos).
    Vitali F; Morgenstern N; Eckstein M; Atreya R; Waldner M; Hartmann A; Neurath MF; Rath T
    Gastrointest Endosc; 2023 Jan; 97(1):100-111.e1. PubMed ID: 36058265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endoscopic scores for inflammatory bowel disease in the era of 'mucosal healing': Old problem, new perspectives.
    Pagnini C; Menasci F; Desideri F; Corleto VD; Delle Fave G; Di Giulio E
    Dig Liver Dis; 2016 Jul; 48(7):703-8. PubMed ID: 27050942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting Mucosal Healing in Crohn's Disease Using Practical Clinical Indices with Regard to the Location of Active Disease.
    Bamba S; Tsujikawa T; Ban H; Imaeda H; Inatomi O; Nishida A; Sasaki M; Andoh A; Fujiyama Y
    Hepatogastroenterology; 2014 May; 61(131):689-96. PubMed ID: 26176058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
    Bryant RV; Winer S; Travis SP; Riddell RH
    J Crohns Colitis; 2014 Dec; 8(12):1582-97. PubMed ID: 25267173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy.
    López-Palacios N; Mendoza JL; Taxonera C; Lana R; López-Jamar JM; Díaz-Rubio M
    Eur J Intern Med; 2011 Dec; 22(6):621-5. PubMed ID: 22075292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Durable Clinical and Biochemical but Not Endoscopic Remission in Pediatric Crohn's Disease on Specific Carbohydrate Diet Monotherapy.
    Britto SL; Kellermayer R
    Ann Clin Lab Sci; 2020 May; 50(3):316-320. PubMed ID: 32581019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.